Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 509

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2

Open access
Arizti-Sanz, Jon, Freije, Catherine A., Stanton, Alexandra C., Petros, Brittany A., Boehm, Chloe K., Siddiqui, Sameed, Shaw, Bennett M., Adams, Gordon, Kosoko-Thoroddsen, Tinna-Solveig F., Kemball, Molly E., Uwanibe, Jessica N., Ajogbasile, Fehintola V., Eromon, Philomena E., Gross, Robin, Wronka, Loni, Caviness, Katie, Hensley, Lisa E., Bergman, Nicholas H., MacInnis, Bronwyn L., Happi, Christian T., Lemieux, Jacob E., Sabeti, Pardis C., Myhrvold, Cameron·2020·Nature Communications

Abstract

The COVID-19 pandemic has highlighted that new diagnostic technologies are essential for controlling disease transmission. Here, we develop SHINE (Streamlined Highlighting of Infections to Navigate Epidemics), a sensitive and specific diagnostic tool that can detect SARS-CoV-2 RNA from unextracted samples. We identify the optimal conditions to allow RPA-based amplification and Cas13-based detection to occur in a single step, simplifying assay preparation and reducing run-time. We improve HUDSON to rapidly inactivate viruses in nasopharyngeal swabs and saliva in 10 min. SHINE’s results can be visualized with an in-tube fluorescent readout — reducing contamination risk as amplification reaction tubes remain sealed — and interpreted by a companion smartphone application. We validate SHINE on 50 nasopharyngeal patient samples, demonstrating 90% sensitivity and 100% specificity compared to RT-qPCR with a sample-to-answer time of 50 min. SHINE has the potential to be used outside of hospitals and clinical laboratories, greatly enhancing diagnostic capabilities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-19097-x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 30

  1. Bai, Y. et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA https://doi.org/10.1001/jama.2020.2565 (2020). · DOI · Paper page
  2. Rothe, C. et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N. Engl. J. Med. 382, 970–971 (2020). · DOI · Paper page
  3. Wang, C., Horby, P. W., Hayden, F. G. & Gao, G. F. A novel coronavirus outbreak of global health concern. Lancet 395, 470–473 (2020). · DOI · Paper page
  4. Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020). · DOI · Paper page
  5. Notomi, T. et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 28, E63 (2000). · DOI · Paper page
  6. Park, G.-S. et al. Development of reverse transcription loop-mediated isothermal amplification assays targeting SARS-CoV-2. J. Mol. Diagn. https://doi.org/10.1016/j.jmoldx.2020.03.006 (2020). · DOI · Paper page
  7. Niemz, A., Ferguson, T. M. & Boyle, D. S. Point-of-care nucleic acid testing for infectious diseases. Trends Biotechnol. 29, 240–250 (2011). · DOI · Paper page
  8. Piepenburg, O., Williams, C. H., Stemple, D. L. & Armes, N. A. DNA detection using recombination proteins. PLoS Biol. 4, e204 (2006). · DOI · Paper page
  9. Qian, J. et al. An enhanced isothermal amplification assay for viral detection. Nat Commun https://doi.org/10.1038/s41467-020-19258-y (2020). · DOI · Paper page
  10. Basu, A. et al. Performance of Abbott ID NOW COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution. J. Clin. Microbiol. https://doi.org/10.1128/JCM.01136-20 (2020). · DOI · Paper page
  11. Svoboda, E. A sticking point for rapid flu tests? Nature 573, S56–S57 (2019). · doi:10.1038/d41586-019-02754-7
  12. Metsky, H. C., Freije, C. A., Kosoko-Thoroddsen, T.-S. F., Sabeti, P. C. & Myhrvold, C. CRISPR-based surveillance for COVID-19 using genomically-comprehensive machine learning design. Preprint at https://www.biorxiv.org/content/10.1101/2020.02.26.967026v2 (2020). · DOI
  13. Broughton, J. P. et al. CRISPR-Cas12-based detection of SARS-CoV-2. Nat. Biotechnol. https://doi.org/10.1038/s41587-020-0513-4 (2020). · DOI · Paper page
  14. Rauch, J. N. et al. A scalable, easy-to-deploy, protocol for Cas13-based detection of SARS-CoV-2 genetic material. Preprint at https://www.biorxiv.org/content/10.1101/2020.04.20.052159v3 (2020). · doi:10.1101/2020.04.20.052159v3
  15. Guo, L. et al. SARS-CoV-2 detection with CRISPR diagnostics. Cell Discov. 6, 1–4 (2020). · DOI · Paper page
  16. Gootenberg, J. S. et al. Nucleic acid detection with CRISPR-Cas13a/C2c2. Science 356, 438–442 (2017). · DOI · Paper page
  17. Abudayyeh, O. O. et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353, aaf5573 (2016). · DOI · Paper page
  18. Myhrvold, C. et al. Field-deployable viral diagnostics using CRISPR-Cas13. Science 360, 444–448 (2018). · DOI · Paper page
  19. Barnes, K. G. et al. Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time. Nat. Commun. 11, 1–10 (2020). · DOI · Paper page
  20. Gootenberg, J. S. et al. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science 360, 439–444 (2018). · DOI · Paper page
  21. East-Seletsky, A., O’Connell, M. R., Burstein, D., Knott, G. J. & Doudna, J. A. RNA targeting by functionally orthogonal type VI-A CRISPR-Cas enzymes. Mol. Cell 66, 373.e3–383.e3 (2017). · DOI · Paper page
  22. Paltiel, A. D., Zheng, A. & Walensky, R .P. Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States. JAMA Netw Open 3, e2016818 (2020). · DOI · Paper page
  23. Williams, E., Bond, K., Zhang, B., Putland, M. & Williamson, D. A. Saliva as a non-invasive specimen for detection of SARS-CoV-2. J. Clin. Microbiol. https://doi.org/10.1128/JCM.00776-20 (2020). · DOI · Paper page
  24. To, K. K.-W. et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect. Dis. 20, 565–574 (2020). · DOI · Paper page
  25. Katzmeier, F. et al. A low-cost fluorescence reader for in vitro transcription and nucleic acid detection with Cas13a. PLoS ONE 14, e0220091 (2019). · DOI
  26. Joung, J. et al. Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing. N Engl J Med. 383, 1492–1494 (2020). · DOI · Paper page
  27. Lu, J. et al. Genomic epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell 181, 997–1003.e9 (2020). · DOI · Paper page
  28. Srivatsan, S. et al. Preliminary support for a ‘dry swab, extraction free’ protocol for SARS-CoV-2 testing via RT-qPCR. Preprint at https://www.biorxiv.org/content/10.1101/2020.04.22.056283v1 (2020). · doi:10.1101/2020.04.22.056283v1
  29. Calvert, A. E., Biggerstaff, B. J., Tanner, N. A., Lauterbach, M. & Lanciotti, R. S. Rapid colorimetric detection of Zika virus from serum and urine specimens by reverse transcription loop-mediated isothermal amplification (RT-LAMP). PLoS ONE 12, e0185340 (2017). · DOI
  30. Rabe, B. A. & Cepko, C. SARS-CoV-2 detection using isothermal amplification and a rapid, inexpensive protocol for sample inactivation and purification. PNAS 117, 24450–24458 (2020). · DOI · Paper page

Cited by

See all 509

Metadata

Authors
Arizti-Sanz, J., Freije, C. A., Stanton, A. C., Petros, B. A., Boehm, C. K., Siddiqui, S., Shaw, B. M., Adams, G., Kosoko-Thoroddsen, T.-S. F., Kemball, M. E., Uwanibe, J. N., Ajogbasile, F. V., Eromon, P. E., Gross, R., Wronka, L., Caviness, K., Hensley, L. E., Bergman, N. H., MacInnis, B. L., Happi, C. T., Lemieux, J. E., Sabeti, P. C., & Myhrvold, C.
Venue
Nature Communications
Published
2020-11-20
Volume
11
Issue
1
Pages
5921-5921
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3103998356
Cited by
509
References
3
FWCI
8.42
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2. https://app.cochat.ai/papers/10.1038/s41467-020-19097-x
The paper
Arizti-Sanz, J., Freije, C. A., Stanton, A. C., Petros, B. A., Boehm, C. K., Siddiqui, S., Shaw, B. M., Adams, G., Kosoko-Thoroddsen, T.-S. F., Kemball, M. E., Uwanibe, J. N., Ajogbasile, F. V., Eromon, P. E., Gross, R., Wronka, L., Caviness, K., Hensley, L. E., Bergman, N. H., MacInnis, B. L., . . . Myhrvold, C. (2020). Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2. Nature Communications. https://doi.org/10.1038/s41467-020-19097-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.